2.76 USD
↗ 0.40 (16.95%)AT CLOSE (11:59 AM EDT)
Connect Biopharma Holdings Limited Ordinary Shares
CNTBNASDAQ • USD
2.78
↗ 0.02 (0.76%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
2.78
↗ 0.02 (0.76%)
Market: CLOSED
Shares of Connect Biopharma Holdings Limited Ordinary Shares (CNTB) are trading at $2.76. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, CNTB trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Sep 2, 2026.
Open?$2.37
High?$2.86
Low?$2.37
Prev. Close?$2.36
Volume?2.6M
Avg. Volume?438.3K
VWAP?$2.64
Rel. Volume?5.96x
Bid / Ask
Bid?$2.32 × 100
Ask?$3.25 × 100
Spread?$0.93
Midpoint?$2.79
Valuation & Ratios
Market Cap?148.6M
Shares Out?63.0M
Float?13.7M
Float %?21.8%
P/E Ratio?N/A
P/B Ratio?5.53
EPS?-$1.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Employees
64
Market Cap
148.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-09-03
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200
SAN DIEGO, CA 92130
Phone: 858-727-1040
SAN DIEGO, CA 92130
Phone: 858-727-1040
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?50
Short Sent.?65
Piotroski F-Score?1/9Weak
Altman Z-Score?-13.38Distress
Confidence?52%Low
Short InterestHigh
Short % of Float?13.26%High
Short Interest?1.8M
Days to Cover?4.5
Free Float13.7M
Avg Daily Volume407.4K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.37Strong
Quick Ratio?2.37Strong
Cash Ratio?1.66Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?5.53FAIR▾
Peers100
S&P34
P/S?50.33HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.7CHEAP▾
S&P97
EV/Sales?41.18HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-257.9%WEAK▾
S&P3
ROA?-159.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-60633000
Enterprise Value?$121.6M
Fundamentals ratios updated end of day